Credentialing Service for DSCSA Compliance
Spherity’s compact app to authenticate direct and indirect Authorized Trading Partners in real-time
CARO's Ecosystem
Get started in three easy steps
Don’t get caught out by the 2023 deadline!
Use Spherity's Credentialing Service CARO to operate as an Authorized Trading Partner (ATP) in DSCSA-regulated electronic product verifications.
Contact Spherity & your VRS
Your VRS provider needs to be integrated with CARO. Please contact us if they are not yet connected. We will invite them to join.
Activate your account
We will invite you to your CARO administrator account, already connected to your VRS provider.
Register as an ATP
Configure your account by accquiring your Identity and ATP Credentials.
Obtain and manage Credentials with confidence
You can acquire your Identity and ATP Credentials from our fully integrated Credential Issuer Legisym without any technical effort or additional contracts.
Effortlessly keep track of VRS interactions
Your VRS provider will be able to present your and verify the counterparty’s credentials to prove ATP status automatically.
Who is affected by the U.S. Drug Supply Chain Security Act (DSCSA)?
Trading partners in the pharmaceutical supply chain
Manufacturer
- Accepts or transfers direct product ownership. Must have valid registration.
Wholesale Distributor
- Accepts or transfers direct product ownership. Must hold valid license.
Dispenser
- Accepts or transfers direct product ownership. Must hold valid license.
Repackager
- Accepts or transfers direct product ownership. Must have valid registration.
Third-Party Logistic Provider
- Accepts or transfers direct product possession. Must hold valid license.
DSCSA Challenge
CARO is helping you close the compliance gap
DSCSA requires new enhancements to pharmaceutical supply chain security by fall 2023.
Having instant assurance that you only interact with trusted and authorized trading partners is a huge challenge.
Challenge accepted
Using CARO you can:
- be sure that the counterparty is who they say they are;
- facilitate automated mutual Authorized Trading Partners checks in direct and indirect interactions;
- interact with counterparties using other OCI-conformant service providers;
- rely on secure messaging.
When using VRS initially, we utilized GLNs to identify a trading partner. We discovered GLNs that were not active or not associated with the requesting entity. GLNs also do not inform about authorized status. Additionally, we had no proof that the provided GLN actually came from the trading partner. This was a compliance gap we had to close.
Dave Mason
Supply Chain Compliance and Serialization Lead, Novartis
From our blog
Looking for a longer read? Enjoy our articles.
Supporting you on your road to compliance
Solve the challenge of ATP authentication today and continue on your road to full DSCSA compliance by fall 2023.
Request a free trial